Articles

Results 1 to 4 of 4


UK Supreme Court hands down decision on obviousness in relation to dosage regime patents - Actavis v ICOS [2019] UKSC 15

United Kingdom - March 28 2019 In a long awaited decision, the UK Supreme Court (Lord Hodge giving the speech on behalf of a unanimous Panel) has dismissed ICOS’s appeal against…

Mike Gilbert

Selecting from lists at the EPO – the “two-lists principle”

European Union - October 21 2015 The European Patent Office (EPO) has a reputation for applying a strict approach to assessment of basis for amendment under added matter (Article…

Clarity in opposition at the EPO – a welcome decision for patentees

European Union - May 1 2015 In its voluminous decision G3/14, the EPO's Enlarged Board of Appeal (EBA) has decided to what extent clarity of the claims may be examined during…

Proposed UK patent reform to benefit life science innovators

United Kingdom - June 2 2014 Proposed changes to the UK Patents Act laid before the parliament on 6 May 2014 are set to provide freedom for life science innovators to perform…